KOLLTAN PHARMACEUTICALS INC — Form D

KOLLTAN PHARMACEUTICALS INC of NEW HAVEN, CT, a company, filed a Form D exempt-offering notice with the SEC on 2012-03-07. The offering totals $25.0M, of which $25.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (31)

Showing 25 of 31 people.

NameRoleLocation
Michael SchmertzlerDirectorNew Haven, CT
Stanley Jonathan ChoyExecutive OfficerNew Haven, CT
Yaron Jonathan HadariExecutive OfficerNew Haven, CT
W. Bradford MiddlekauffExecutive OfficerExton, PA
Michael SchmertzlerExecutive OfficerNew Haven, CT
K. Peter HirthDirectorSouth San Francisco, CA
Peter HirthDirectorSouth San Francisco, CA
E. Jonathan SoderstromDirectorNew Haven, CT
Joseph SchlessingerDirectorWoodbridge, CT
Joseph SchlessingerPromoterWoodbridge, CT
Axel BolteDirectorBoston, MA
Gerald McMahonDirectorSouth San Francisco, CA
Gerald McMahonExecutive OfficerSouth San Francisco, CA
Jane Pritchett HendersonExecutive OfficerNew York, NY
Axel G BolteDirectorNew Haven, CT
Paul Jonathan MedeirosDirectorNew Haven, CT
Stanley Pritchett ChoyExecutive OfficerNew Haven, CT
Yaron Pritchett HadariExecutive OfficerNew Haven, CT
Theresa M LaValleeExecutive OfficerNew Haven, CT
Joseph B SchlessingerDirectorNew Haven, CT
Carolyn F SidorExecutive OfficerNew Haven, CT
Arthur G Altschul, Jr.DirectorNew Haven, CT
Arthur G Altschul, Jr.Executive OfficerNew Haven, CT
Arthur G Altschul, Jr.PromoterNew Haven, CT
Thomas B NeffDirectorSan Francisco, CA

Other filings by this issuer (5)

FiledFormOfferingSold
2014-03-19D$60.0M$60.0M
2010-09-16D/A$7.5M$6.0M
2010-01-04D$2.5M$2.5M
2009-09-08D$7.5M$3.5M
2009-08-12D/A$40.0M$40.0M

More